Press releases

Advanced Search
  • Nov 20, 2014

    Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements...

  • Nov 6, 2014
    Revenue increased 11 percent to $922 million

    SAN DIEGO, Nov. 6, 2014 /PRNewswire/ – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its first quarter of fiscal 2015, ended...

  • Nov 4, 2014
    -- Reports fourth quarter adjusted diluted earnings per share from continuing operations of $1.68. This represents growth of 13.0 percent on a currency-neutral basis, or 9.1 percent including the unfavorable impact of foreign currency. Reported diluted earnings per share from continuing operations for the fourth quarter were $1.53.

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.202 billion for the fourth fiscal quarter ended September 30,...

  • Oct 13, 2014
    Transaction Advances BD’s Entry into Next Generation Sequencing Market

    FRANKLIN LAKES, N.J., October 13, 2014 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has acquired GenCell Biosystems, a...

  • Oct 5, 2014
    Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions

    BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to...